4 Results for "

human PDE4B1

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "human PDE4B1" in MCE Product Catalog:

Cat. No.: HY-155830
CAS No.: 2231329-25-0
Purity:  98.92%
Synonyms: ME3183; PDE4-IN-14
Morcamilast (ME3183) is a potent, orally active, selective phosphodiesterase 4 (PDE4) inhibitor, with IC50 values of 1.28 nM, 2.33 nM and 1.63 nM against human PDE4A1A, PDE4B1 and PDE4D2, respectively. Morcamilast inhibits the production of TNF-α, IL-12/23p40, IL-23, IL-17A, IL-4, IL-5 and IL-13 in human PBMCs and T cells, and alleviates chronic Oxazolone (HY-126360)-induced dermatitis, Substance P (HY-P0201)-induced pruritus, Imiquimod (HY-B0180)-induced psoriasis-like dermatitis and LPS (HY-D1056)-induced arthritis . Morcamilast is used for the research of psoriasis, atopic dermatitis, psoriatic arthritis and other inflammatory and immune-related diseases .
loading...
    loading...
Cat. No.: HY-167233
CAS No.: 2229043-40-5
Research Areas:  

Infection

NPD-039 is a selective tetrahydrophthalazinone-class TbrPDEB1 inhibitor with a Ki of 99 nM. NPD-039 occupies the hydrophobic clamp and the parasite-specific P-pocket of TbrPDEB1, and its glycinamide tail forms direct and water-mediated hydrogen bond interactions within the P-pocket. NPD-039 can be used in related research on Human African Trypanosomiasis .
loading...
    loading...
Cat. No.: HY-165597
CAS No.: 2229043-42-7
Research Areas:  

Infection

NPD-008 is a tetrahydrophthalazinone-based phosphodiesterase inhibitor. It exerts antiparasitic activity by binding to the active site of TbrPDEB1 to block cAMP degradation, increasing intracellular cAMP levels in trypanosomatid parasites, disrupting cellular structure, and inhibiting cytokinesis. NPD-008 is used in research on Chagas disease, leishmaniasis, and human African trypanosomiasis .
loading...
    loading...
Cat. No.: HY-181646
CAS No.: 3052591-16-6
PDE4-IN-34 is a phosphodiesterase 4 (PDE4) inhibitor, with IC50 values of 19 pM and 14 pM against PDE4B1 and PDE4D2, respectively. PDE4-IN-34 shows weak inhibitory activity against PDE8A1, with an IC50 value of 4.092 μM, and exhibits significant selectivity over other subtypes (IC50 > 10 μM). PDE4-IN-34 improves pulmonary function, reduces inflammatory responses and alleviates lung tissue damage in a rat model induced by cigarette smoke combined with LPS (HY-D1056). PDE4-IN-34 can be used for research related to chronic obstructive pulmonary disease .
loading...
    loading...